KAIROS PHARMA, LTD. Current Liabilities
KAIROS PHARMA, LTD. (KAPA) had Current Liabilities of $265.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $265.00K.
- 2026-03-31: Liabilities, Current $431.00K.
- 2025-12-31: Liabilities, Current $199.00K.
- 2025-09-30: Liabilities, Current $402.00K.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $265.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $431.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $199.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $402.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $676.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $805.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $992.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.67M 10-Q · filed 2024-11-14 |
| 2023-12-31 | $2.40M 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |